By combining chemotherapy, tumor injury, and immunotherapy, researchers show that the immune system can be re-engaged to destroy tumors in mice.
MIT engineers devised a way to count elusive circulating tumor cells in mice, allowing them to study the dynamics of metastasis.
Neural network identifies synergistic drug blends for treating viruses like SARS-CoV-2.
The head of MIT’s Department of Chemical Engineering will serve on the President’s Council of Advisors on Science and Technology.
The researchers hope scientists and regulators will consider a broader class of compounds in evaluating cancer risk due to PAH exposure.
Vaccinating against certain proteins found on cancer cells could help to enhance the T cell response to tumors.
Studying these organoids could help researchers develop and test new treatments for pancreatic cancer, one of the deadliest types of cancer.
Pioneering scientist isolated, characterized, and established the mechanisms of many environmental toxins relevant to public health.
Researchers find three immunotherapy drugs given together can eliminate pancreatic tumors in mice.
Diagnostic nanoparticles could be used to monitor tumor recurrence after treatment or to perform routine cancer screenings.
The Hansen Lab investigates how genetic elements, known as enhancers, control the expression of genes in cancer.
Implant surface topography can influence the development of scarring, inflammation, and other complications, researchers find.